Literature DB >> 32169225

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

D A Eichenauer1, B M P Aleman2, M André3, M Federico4, M Hutchings5, T Illidge6, A Engert1, M Ladetto7.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32169225     DOI： 10.1093/annonc/mdy080

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

Review 1.  Hodgkin lymphoma.

Authors:  Joseph M Connors; Wendy Cozen; Christian Steidl; Antonino Carbone; Richard T Hoppe; Hans-Henning Flechtner; Nancy L Bartlett
Journal:  Nat Rev Dis Primers       Date:  2020-07-23       Impact factor: 52.329

2.  Cumulative radiation doses due to nuclear medicine examinations: a systematic review.

Authors:  Marco Brambilla; Agnieszka Kuchcińska; Roberta Matheoud; Alfredo Muni
Journal:  Br J Radiol       Date:  2021-08-11       Impact factor: 3.629

Review 3.  The role of HER2 alterations in clinicopathological and molecular characteristics of breast cancer and HER2-targeted therapies: a comprehensive review.

Authors:  Shafighe Asgari-Karchekani; Armin Aryannejad; Seied Asadollah Mousavi; Shirin Shahsavarhaghighi; Seyed Mohammad Tavangar
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

4.  The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19.

Authors:  Wulyo Rajabto; Vitya Chandika; Agnes Stephanie Harahap; Maria Francisca Ham
Journal:  Int Med Case Rep J       Date:  2022-06-01

5.  PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial.

Authors:  M Picardi; C Cavaliere; R Della Pepa; E Nicolai; A Soricelli; C Giordano; N Pugliese; M G Rascato; I Cappuccio; G Campagna; C Cerchione; E Vigliar; G Troncone; M Mascolo; M Franzese; R Castaldo; M Salvatore; F Pane
Journal:  Ann Hematol       Date:  2021-04-28       Impact factor: 3.673

Review 6.  AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL.

Authors:  Zuoqiao Wu; Mary Nicoll; Robert J Ingham
Journal:  Exp Hematol Oncol       Date:  2021-01-07

Review 7.  FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated Overview.

Authors:  Conrad-Amadeus Voltin; Jasmin Mettler; Jirka Grosse; Markus Dietlein; Christian Baues; Christine Schmitz; Peter Borchmann; Carsten Kobe; Dirk Hellwig
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639

Review 8.  Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective.

Authors:  Anna Sureda; Marc André; Peter Borchmann; Maria G da Silva; Christian Gisselbrecht; Theodoros P Vassilakopoulos; Pier Luigi Zinzani; Jan Walewski
Journal:  BMC Cancer       Date:  2020-11-10       Impact factor: 4.430

9.  Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.

Authors:  David A Jones; Paolo Candio; Rebecca Shakir; Georgios Ntentas; Johanna Ramroth; Alastair M Gray; David J Cutter
Journal:  Blood Adv       Date:  2022-02-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.